Johan Folkunger

Before joining DNV Imatis in Janauary 2023, Johan was the CEO of the Swedish publicly traded company SpectraCure developing a treatment modality for recurring prostate cancer. Prior to SpectraCure, Johan was the Executive Vice President of the Swedish publicly traded investment company MedCap where he oversaw and managed the medtech branch of MedCap.

Johan also spent 8 years with Philips, amongst other things as Country Manager for the Health Systems business and CEO of Philips as a whole in Sweden. In addition to his position as CEO of DNV Imatis Johan holds two board positions. As Chairman of the board of Directors of the Cardiolex group specialised in digital enterprise ECG solutions and as member of the board of Directors of the Norwegian company Medu AS.